Corporate Snapshot: Apt Medical’s Recent Performance
Apt Medical (688617.SS) closed the trading day on Wednesday, 21 October 2026, unchanged at 0 % relative to the previous close. The Shanghai Stock Exchange reported the closing price at CNY 258.7 per share, a figure that reflects the company’s steady valuation amid a volatile market environment.
Trading Dynamics
During the 24‑hour period ending at 07:36 AM Central Europe, the company’s shares saw a cumulative trading volume of approximately CNY 343.8 million. This volume corresponds to roughly 1.25 % of the 137 million shares that remain available in the market, underscoring a moderate liquidity profile.
Apt Medical’s market capitalization currently sits at CNY 34.7 billion, a modest increase of 4.02 % since the end of last month. This uptick comes against a backdrop of broader sector volatility, as reflected in the performance of peer firms listed below.
Technical Indicators
- 200‑Day Simple Moving Average (SMA): The company trades above its 200‑day SMA of CNY 221.15, suggesting a bullish trend over the medium term.
- 52‑Week High/Low: The share’s price peaked at CNY 337.2 on 24 October 2025, while the 52‑week low settled at CNY 176.28 on 29 June 2026. The current price of CNY 258.7 places the stock roughly midway between these extremes, indicating a potentially stable valuation zone.
Peer Comparison
| Company | Ticker | Current Price | Market Cap | P/E Ratio | 24‑Hour Movement |
|---|---|---|---|---|---|
| Sinopharm –H | 1099.HK | HKD 15.84 | HKD 48.7 bn | 5.9 | +0.45 % |
| Zhejiang Cfmoto Power L | 603129.SS | CNY 289.27 | CNY 41.2 bn | 24.61 | 0 % |
| Shanghai Putailai New Energy | 603659.SS | CNY 19.02 | CNY 41 bn | 14.73 | 0 % |
| Qilu Bank | 601665.SS | CNY 6.63 | CNY 40.7 bn | 7.2 | 0 % |
| Puya Semiconductor Shangha | 688766.SS | CNY 286.38 | CNY 41.3 bn | 58.48 | 0 % |
Apt Medical’s performance aligns with a broader trend of relative stability across the listed peers, many of which traded flat or marginally positive over the same period.
Company Profile
APT Medical Inc. is headquartered in Shanghai and is a prominent player in China’s biotechnology arena. The firm focuses on developing innovative therapeutic solutions, particularly in cardiovascular disease. Its research pipeline and commercial strategy position it as a key contributor to the domestic medical technology landscape.
Outlook
Given its position above the 200‑day SMA, the absence of significant short‑term volatility, and a market cap that has grown modestly month‑over‑month, Apt Medical appears to maintain a solid footing within the sector. Investors may view the current price range as a potential entry point, especially if the company’s research milestones continue to materialise.
The information herein is based on publicly available trading data as of 21 October 2026 and is intended for informational purposes only.
